Skip to main content
Perseus Proteomics Inc. logo

Perseus Proteomics Inc. — Investor Relations & Filings

Ticker · 4882 ISIN · JP3836800007 T Professional, scientific and technical activities
Open in API
Filings indexed 56 across all filing types
Latest filing 2023-11-13 Regulatory Filings
Country JP Japan
Listing T 4882

About Perseus Proteomics Inc.

https://www.ppmx.com/en/

Perseus Proteomics Inc. is a drug discovery biotechnology company specializing in the development of novel antibody-based therapeutics and diagnostics. Originating from the University of Tokyo, the company leverages proprietary antibody technologies and screening platforms to create a pipeline of drug candidates targeting cancer and other diseases. Its business is structured into three main segments: Drug Discovery, which focuses on its internal pipeline; Antibody Research Support, offering services to the research community; and Antibody/Reagent Sales, which provides products like ELISA kits. The company aims to contribute to global healthcare through its advanced antibody-based solutions.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act Article 24-4-8. It serves as an officer certification regarding the accuracy of a quarterly report, rather than the quarterly report itself. Per the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q2 2023
2023-11-13 Japanese
四半期報告書－第24期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Perseus Proteomics Inc., covering the second quarter of the 24th fiscal period (July 1, 2023, to September 30, 2023). It contains detailed financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-13 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, specifically related to a correction of a previously filed Annual Securities Report (有価証券報告書). Since it is a regulatory filing regarding the accuracy of financial reporting and does not fit into specific categories like 10-K or IR, it falls under the general regulatory filing category. FY 2023
2023-11-06 Japanese
訂正有価証券報告書－第23期(2022/04/01－2023/03/31)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (訂正有価証券報告書) for an Annual Securities Report (有価証券報告書). It contains detailed financial data, business indicators, and corporate history for the fiscal year ending March 31, 2023. Although it is a correction, it functions as the primary annual financial disclosure document (10-K equivalent in the Japanese market). FY 2023
2023-11-06 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the First Quarter Report (Dai-ichi shihanki hokokusho). While it references the quarterly report, this specific document is a standalone regulatory filing confirming the accuracy of the financial statements, which falls under the category of regulatory filings or audit-related compliance documentation. Given the specific nature of the filing as a confirmation of report accuracy, it is best classified as a Regulatory Filing (RNS).
2023-08-14 Japanese
四半期報告書－第24期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Perseus Proteomics Inc., covering the first quarter of the 24th fiscal year (April 1, 2023, to June 30, 2023). It contains detailed financial statements (balance sheet, income statement) and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-14 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.